| Title : The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial - Lerman_2004_Pharmacogenomics.J_4_184 |
| Author(s) : Lerman C , Wileyto EP , Patterson F , Rukstalis M , Audrain-McGovern J , Restine S , Shields PG , Kaufmann V , Redden D , Benowitz N , Berrettini WH |
| Ref : Pharmacogenomics J , 4 :184 , 2004 |
| Abstract : Lerman_2004_Pharmacogenomics.J_4_184 |
| ESTHER : Lerman_2004_Pharmacogenomics.J_4_184 |
| PubMedSearch : Lerman_2004_Pharmacogenomics.J_4_184 |
| PubMedID: 15007373 |
Lerman C, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Restine S, Shields PG, Kaufmann V, Redden D, Benowitz N, Berrettini WH (2004)
The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial
Pharmacogenomics J
4 :184
Lerman C, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Restine S, Shields PG, Kaufmann V, Redden D, Benowitz N, Berrettini WH (2004)
Pharmacogenomics J
4 :184